Australia markets closed

Equillium, Inc. (EQ)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
5.86-0.17 (-2.82%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close6.03
Open5.99
Bid5.70 x 2200
Ask6.22 x 900
Day's range5.66 - 5.99
52-week range3.47 - 11.33
Volume71,583
Avg. volume107,520
Market cap172.183M
Beta (5Y monthly)1.50
PE ratio (TTM)N/A
EPS (TTM)-1.31
Earnings date08 Nov 2021 - 12 Nov 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est14.00
  • Business Wire

    Equillium Announces Two Abstracts Accepted for Presentation at the Upcoming Virtual 2021 American Society of Nephrology Annual Meeting

    LA JOLLA, Calif., October 18, 2021--Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company developing itolizumab to treat severe autoimmune and inflammatory disorders with high unmet medical need, today announced that two abstracts were accepted for presentation at the virtual 2021 American Society of Nephrology (ASN) Annual Meeting to be held November 4-7, 2021.

  • Business Wire

    Equillium Announces Multiple Abstracts Accepted for Presentation at ACR Convergence 2021

    LA JOLLA, Calif., September 30, 2021--Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company developing itolizumab to treat severe autoimmune and inflammatory disorders with high unmet medical need, today announced that three abstracts were accepted for presentation at ACR Convergence, the annual meeting of the American College of Rheumatology. The meeting, the world’s premier virtual rheumatology experience, will take place online November 3 - 10.

  • Business Wire

    Equillium to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference

    LA JOLLA, Calif., September 22, 2021--Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company developing itolizumab to treat severe autoimmune and inflammatory disorders with high unmet medical need, today announced that it will participate in a fireside chat presentation at the Cantor Fitzgerald Virtual Global Healthcare Conference, taking place September 27 – 30, 2021.